|
Jul 1
|
Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29
|
|
Jun 30
|
BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock?
|
|
Jun 30
|
Gilead extends gains after Supreme Court upheld an Obamacare provision
|
|
Jun 28
|
Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial
|
|
Jun 28
|
Should You Count on MRK for Steady Passive Income?
|
|
Jun 27
|
Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations
|
|
Jun 27
|
Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?
|
|
Jun 26
|
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
|
|
Jun 26
|
Merck’s RSV shot for infants gets key approval despite RFK Jr.’s panel shakeup
|
|
Jun 26
|
ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
|
|
Jun 26
|
Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?
|
|
Jun 26
|
Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies
|
|
Jun 26
|
2 Stocks Too Cheap to Ignore at These Prices
|
|
Jun 25
|
Stifel Downgrades Zoetis (ZTS) Stock, Reduces PT
|
|
Jun 17
|
Exiger CMO Kody Gurfein Wins PRNews' Top Women Award
|
|
Jun 13
|
RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit
|
|
Jun 13
|
Citizens Financial, Merck, oil producers: Trending Tickers
|
|
Jun 13
|
Investors should be 'embracing volatility'
|
|
Jun 13
|
FDA Approves KEYTRUDA® (pembrolizumab) for PD-L1+ Resectable Locally Advanced Head & Neck Squamous Cell Carcinoma as Neoadjuvant Treatment, Continued as Adjuvant Treatment Combined With Radiotherapy With or Without Cisplatin Then as a Single Agent
|
|
Jun 13
|
MSD begins Phase III trial of dengue vaccine
|